新冠疫情中的抗菌药物管理
Antimicrobial Stewardship in the Covid-19 Pandemic.
作者信息
Venturini Sergio, Avolio Manuela, Fossati Sara, Callegari Astrid, De Rosa Rita, Basso Barbara, Zanusso Chiara, Orso Daniele, Cugini Francesco, Crapis Massimo
机构信息
Santa Maria degli Angeli Hospital Pordenone, Pordenone, Friuli-Venezia Giulia, Italy.
Santa Maria della Misericordia University Hospital, Udine, Friuli-Venezia Giulia, Italy.
出版信息
Hosp Pharm. 2022 Aug;57(4):416-418. doi: 10.1177/00185787221075190. Epub 2022 Feb 10.
Abstract
During COVID-19 pandemic, implementing and maintaining an antimicrobial stewardship protocol obtained both low rates of MDR microorganisms and low antimicrobial use in an 800-bed hospital network in northern Italy. Infectious diseases specialist consulting was crucial to maintain this protocol active.
摘要
在新冠疫情期间，意大利北部一个拥有800张床位的医院网络实施并维持抗菌药物管理方案，耐多药微生物发生率和抗菌药物使用率均较低。传染病专科医生的咨询对于维持该方案的有效实施至关重要。
相似文献
1
Antimicrobial Stewardship in the Covid-19 Pandemic.新冠疫情中的抗菌药物管理
Hosp Pharm. 2022 Aug;57(4):416-418. doi: 10.1177/00185787221075190. Epub 2022 Feb 10.
2
Impact of the COVID-19 Pandemic on Antimicrobial Consumption and Hospital-Acquired Candidemia and Multidrug-Resistant Bloodstream Infections.2019年冠状病毒病大流行对抗菌药物使用以及医院获得性念珠菌血症和多重耐药血流感染的影响
Antibiotics (Basel). 2020 Nov 17;9(11):816. doi: 10.3390/antibiotics9110816.
3
What is the impact of SARS-CoV-2 pandemic on antimicrobial stewardship programs (ASPs)? The results of a survey among a regional network of infectious disease centres.SARS-CoV-2 大流行对抗菌药物管理项目（ASPs）有何影响？一项针对传染病中心区域网络的调查结果。
Antimicrob Resist Infect Control. 2022 Aug 29;11(1):108. doi: 10.1186/s13756-022-01152-5.
4
[Organisational and staff requirements for antimicrobial stewardship activities in hospitals : Position paper of the Commission on Anti-Infectives, Resistance and Therapy (Commission ART) at the Robert Koch Institute, with advice from professional associations].[医院抗菌药物管理活动的组织与人员要求：罗伯特·科赫研究所抗感染、耐药性与治疗委员会（ART委员会）立场文件，并参考专业协会建议]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2020 Jun;63(6):749-760. doi: 10.1007/s00103-020-03152-5.
5
Antimicrobial stewardship in a Gastroenterology Department: Impact on antimicrobial consumption, antimicrobial resistance and clinical outcome.消化内科的抗菌药物管理：对抗菌药物使用、抗菌药物耐药性及临床结局的影响
Dig Liver Dis. 2016 Oct;48(10):1142-7. doi: 10.1016/j.dld.2016.06.023. Epub 2016 Jun 30.
6
Antimicrobial Stewardship in Hematological Patients at the intensive care unit: a global cross-sectional survey from the Nine-i Investigators Network.血液科重症监护病房患者的抗菌药物管理：来自 Nine-i 研究人员网络的全球横断面调查。
Eur J Clin Microbiol Infect Dis. 2020 Feb;39(2):385-392. doi: 10.1007/s10096-019-03736-3. Epub 2019 Nov 9.
7
The Impact of the COVID-19 Pandemic on Antimicrobial Resistance and Management of Bloodstream Infections.新冠疫情对耐药性及血流感染管理的影响
Pathogens. 2023 May 30;12(6):780. doi: 10.3390/pathogens12060780.
8
Antimicrobial stewardship perspectives from a New York City hospital during the COVID-19 pandemic: Challenges and opportunities.新冠疫情期间纽约市一家医院的抗菌药物管理视角：挑战与机遇。
Am J Health Syst Pharm. 2021 Mar 31;78(8):743-750. doi: 10.1093/ajhp/zxaa419.
9
Antimicrobial resistance research in a post-pandemic world: Insights on antimicrobial resistance research in the COVID-19 pandemic.大流行后世界的抗菌药物耐药性研究：关于新冠疫情中抗菌药物耐药性研究的见解
J Glob Antimicrob Resist. 2021 Jun;25:5-7. doi: 10.1016/j.jgar.2021.02.013. Epub 2021 Mar 1.
10
Rationale and guidance for strengthening infection prevention and control measures and antimicrobial stewardship programs in Bangladesh: a study protocol.强化孟加拉国感染预防与控制措施及抗菌药物管理项目的理由与指导：一项研究方案。
BMC Health Serv Res. 2022 Oct 7;22(1):1239. doi: 10.1186/s12913-022-08603-0.
引用本文的文献
1
Antimicrobial Stewardship in COVID-19 Patients: Those Who Sow Will Reap Even through Hard Times.COVID-19患者的抗菌药物管理：播种者即使历经艰难也会收获。
Antibiotics (Basel). 2023 Jun 4;12(6):1009. doi: 10.3390/antibiotics12061009.
本文引用的文献
1
MDRO transmission in acute hospitals during the COVID-19 pandemic.新冠疫情期间急性医院中的多重耐药菌传播。
Curr Opin Infect Dis. 2021 Aug 1;34(4):365-371. doi: 10.1097/QCO.0000000000000735.
2
Antibiotic prescribing in patients with COVID-19: rapid review and meta-analysis.COVID-19 患者的抗生素处方：快速综述和荟萃分析。
Clin Microbiol Infect. 2021 Apr;27(4):520-531. doi: 10.1016/j.cmi.2020.12.018. Epub 2021 Jan 5.
3
Impact of the COVID-19 Pandemic on Antimicrobial Consumption and Hospital-Acquired Candidemia and Multidrug-Resistant Bloodstream Infections.2019年冠状病毒病大流行对抗菌药物使用以及医院获得性念珠菌血症和多重耐药血流感染的影响
Antibiotics (Basel). 2020 Nov 17;9(11):816. doi: 10.3390/antibiotics9110816.
4
Collateral damage of the COVID-19 pandemic: Exacerbation of antimicrobial resistance and disruptions to antimicrobial stewardship programmes?2019年冠状病毒病疫情的附带损害：抗菌药物耐药性加剧及抗菌药物管理计划受到干扰？
S Afr Med J. 2020 Jun 2;110(7):572-573. doi: 10.7196/SAMJ.2020.v110i7.14917.
5
Bacterial co-infection and secondary infection in patients with COVID-19: a living rapid review and meta-analysis.COVID-19 患者的细菌合并感染和继发感染：一项实时快速综述和荟萃分析。
Clin Microbiol Infect. 2020 Dec;26(12):1622-1629. doi: 10.1016/j.cmi.2020.07.016. Epub 2020 Jul 22.
6
Co-infections in people with COVID-19: a systematic review and meta-analysis.COVID-19 患者合并感染：系统评价和荟萃分析。
J Infect. 2020 Aug;81(2):266-275. doi: 10.1016/j.jinf.2020.05.046. Epub 2020 May 27.
7
COVID-19 and the potential long-term impact on antimicrobial resistance.COVID-19 与潜在的长期抗菌药物耐药性影响
J Antimicrob Chemother. 2020 Jul 1;75(7):1681-1684. doi: 10.1093/jac/dkaa194.
8
COVID-19: don't neglect antimicrobial stewardship principles!2019冠状病毒病：勿忽视抗菌药物管理原则！
Clin Microbiol Infect. 2020 Jul;26(7):808-810. doi: 10.1016/j.cmi.2020.04.024. Epub 2020 Apr 30.
9
Bacterial and Fungal Coinfection in Individuals With Coronavirus: A Rapid Review To Support COVID-19 Antimicrobial Prescribing.细菌和真菌合并感染冠状病毒的个体：一项支持 COVID-19 抗菌药物处方的快速综述。
Clin Infect Dis. 2020 Dec 3;71(9):2459-2468. doi: 10.1093/cid/ciaa530.
10
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China.中国武汉地区 2019 年新型冠状病毒感染患者的临床特征。
Lancet. 2020 Feb 15;395(10223):497-506. doi: 10.1016/S0140-6736(20)30183-5. Epub 2020 Jan 24.
Zotero 插件